In conclusion, we identified an enhancer region within the TP63/LEPREL1 intergenic locus containing bladder cancer risk SNPs that regulate gene expression levels in cis and, subsequently, tumor cell viability. Here, TP63 is linked to urinary bladder carcinoma.